-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On the 11th, the State Council Information Office held a regular briefing on policies of the State Council to introduce the progress of deepening the reform of centralized procurement of drugs and high-value medical consumables
.
Regarding whether the provincial and alliance centralized procurement will be included in the national centralized procurement, Chen Jinfu, deputy director of the National Medical Insurance Bureau, said that it depends on the specific situation: If the local recruitment exploration at the provincial level is successful, it is possible that other provinces will follow up with it.
The price is reasonable, and the clinical needs are met, and it is not necessary for the state to organize centralized procurement
.
If the inter-provincial alliance is explored, but the competition pattern is not sufficient, the varieties are not many, and the total volume is not very large, on the basis of the successful exploration mechanism, the state will organize centralized procurement, so that the effect of this reform system can quickly benefit the whole country.
, serving the clinic
.
For example, the centralized procurement of insulin, which was explored in Wuhan the year before last, was quickly organized at the national level to conduct centralized procurement based on the successful experience of the exploration.
This is a two-way system coordination
.
Regarding the centralized procurement price competition that the industry is concerned about, Chen Jinfu made it clear: "We do not pursue the lowest price, and we are firmly opposed to running bidding
.
We do not particularly anchor the international lowest price, because China is moving towards the path of common prosperity, and we Chinese can also eat it.
With good medicines, medical insurance funds can also afford such reasonably priced medicines
.
Therefore, the design of this competition rule actually has a mechanism for reasonable price adjustment, how to make the market discover value and make it more reasonable for enterprises to compete fairly
.
”
.
Regarding whether the provincial and alliance centralized procurement will be included in the national centralized procurement, Chen Jinfu, deputy director of the National Medical Insurance Bureau, said that it depends on the specific situation: If the local recruitment exploration at the provincial level is successful, it is possible that other provinces will follow up with it.
The price is reasonable, and the clinical needs are met, and it is not necessary for the state to organize centralized procurement
.
If the inter-provincial alliance is explored, but the competition pattern is not sufficient, the varieties are not many, and the total volume is not very large, on the basis of the successful exploration mechanism, the state will organize centralized procurement, so that the effect of this reform system can quickly benefit the whole country.
, serving the clinic
.
For example, the centralized procurement of insulin, which was explored in Wuhan the year before last, was quickly organized at the national level to conduct centralized procurement based on the successful experience of the exploration.
This is a two-way system coordination
.
Regarding the centralized procurement price competition that the industry is concerned about, Chen Jinfu made it clear: "We do not pursue the lowest price, and we are firmly opposed to running bidding
.
We do not particularly anchor the international lowest price, because China is moving towards the path of common prosperity, and we Chinese can also eat it.
With good medicines, medical insurance funds can also afford such reasonably priced medicines
.
Therefore, the design of this competition rule actually has a mechanism for reasonable price adjustment, how to make the market discover value and make it more reasonable for enterprises to compete fairly
.
”